InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Shiff Susan Ph.D., 董事. Insider active across 1 company, notably Cara Therapeutics, Inc.. Aggregated, 4 disclosures have been recorded. Activity tracked since 3 June 2021. The latest transaction was disclosed on 4 June 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Shiff Susan Ph.D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
150,647 股0Common StockSEC:0001415889-24-015756:0
32,362 股0Common StockSEC:0001209191-23-034330:0
11,876 股0Common StockSEC:0001209191-22-034627:0
7,200 股0Common StockSEC:0001209191-21-038765:0
4 条申报中的 4 条
About Shiff Susan Ph.D.
Susan Ph.D. Shiff is a Board Member of Cara Therapeutics, Inc. She brings expertise in research and development in the pharmaceutical field. Her role involves overseeing the company's research initiatives, which focus on pain management treatments.
